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Abstract
Inhaled medications are the preferred therapies for patients with asthma and COPD, but their effectiveness is limited by the patient’s
ability to use the device properly, an issue often neglected when these medications are prescribed. Correct inhaler technique must be
taught and learnt, and requires educational and motivational programs aimed at patients and healthcare providers alike. Written
instructions alone are manifestly insufficient: education must include practical demonstration and periodic re-assessment and re-
education, since correct technique and motivation usually deteriorate with time. Several devices are available on the market, the purpose
of which is to train patients to use inhalers correctly. They are often directed at particular devices or groups of devices and/or particular
critical aspects of technique. This paper reviews the devices currently available for training patients in the correct use of both pressurised
metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs).
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Introduction
Inhaled drugs play an important role in the treatment of
asthma and chronic obstructive pulmonary disease (COPD),
but their effectiveness and benefit/risk ratios are critically
dependent upon delivery to their appropriate targets in the
respiratory tract and, ideally, nowhere else.1 This requires that
patients use delivery devices in a manner shown to optimise
drug delivery. Otherwise, therapeutic benefit is reduced and
the risk of adverse events increased – and both of these
outcomes may in turn compromise compliance.2,3
The inhalation devices most commonly used are
pressurised metered-dose inhalers (pMDIs) and dry-powder
inhalers (DPIs). Both deliver a precise amount of drug in the
form of aerosol particles of a size suitable for reaching the
conducting airways, but only if used properly. Some patients
cannot use particular devices because of factors such as age,
disability and inadequate lung function. Even when patients
can in theory use a particular device, errors of technique,
some of which may critically compromise drug delivery, are
well known to be frequent.2-5 With pMDIs, two of the most
critical errors are failure to coordinate inhalation with
actuation of the device,6 and inhaling the aerosol too quickly.7
With DPIs, successful aerosolisation of the dry powder
depends on both the velocity and the acceleration of the
inhalation manoevre, which in turn requires rapid and forceful
inhalation.8 Problems are further increased when patients use
more than one type of inhaler, resulting in confusion in terms
of the different techniques required for each.9
Although coaching can improve the ability to use inhalers,
it has been found that many patients revert to an incorrect
inhalation technique within a short period.4,10 Thus, regular
monitoring of inhalation techniques is necessary. Because the
full potential of inhaled drugs cannot be achieved unless
patients understand how to properly use inhaler devices,
there is a need to train patients more effectively in following
a proper sequence of inhalation steps in order to ensure
maximum delivery of an inhaled drug to receptor sites in the
lungs. Accordingly, there is a need for an inhalation training
apparatus which will provide the patent and physician with a
‘real-time’, interactive representation of the inhalation
process. Ideally, an inhalation training apparatus would
provide visual feedback representing the actual distribution of
inhaled aerosol in the lungs and show with reasonable
accuracy the amount of aerosol delivered to the receptor sites.
Such feedback would convey a conceptual understanding of
the proper inhalation process, and thereby increase the
likelihood that the patient would retain the correct technique.
To date, various aids have appeared which are designed to
help patients use inhalers correctly and efficiently. Some of
these provide real-time, interactive sensory feedback of the
patient’s performance in various critical aspects of inhalation
technique, which would seem optimal for “instilling” the
correct technique into the patient’s subconscious, but many
do not. 
In this article we review the tools for training patients in
the correct use of both pMDIs and DPIs. 
Training tools
1. “2Tone” Metered-Dose Inhaler Training Device 
The “2Tone” Metered-Dose Inhaler Training Device, or “2Tone”
Trainer, (Canday Medical Ltd, Newmarket, UK) is a training aid to
help patients inhale aerosolised particles from pMDIs at a rate
optimal for airways deposition. Most untrained patients inhale
far too quickly from a pMDI and this is one error of pMDI
technique which can critically reduce drug delivery.7 The training
device looks similar to a pMDI but contains no medication or
propellant (see Figure 1). All of the components are
manufactured from medical grade plastics; it has been designed
as a "single patient use" device for hygienic reasons, and should
be cleaned at least once a month. The device is available in
several European countries as well as in the USA. The patient
information leaflet provided with this training aid encourages
patients to practice using the device in the same way that they
would use their pMDI. During use, the “2Tone” mimics what it
is like to inhale through a pMDI and provides audible feedback
on how fast air is being inhaled.7 A pair of sensitive reeds vibrate
when air flows through them above a certain pre-determined
speed, producing a single tone with optimal inhalation rates (30-
60 l/min), two tones if the rate is too fast (>60 l/min), and no
noise at all if it is too slow. Patients are advised to obtain the one-
tone noise and thus become accustomed to the degree of
inspiratory effort they need to make to achieve this rate through
a pMDI. Compared with verbal training, the “2Tone” has been
shown to produce sustained improvement in inhalation
Figure 1.  “2Tone” Metered-Dose Inhaler Training Device.
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technique, lung function and quality of life in asthmatics using
pMDIs, presumably because of better deposition of drug within
the airways.7 Furthermore, improvements in asthma quality of life
and lung function were obtained without changing the dose and
without having to retrain the technique.7 These findings
highlight the potential of the “2Tone” to decrease costs as well
as to improve health-care outcomes. 
2. Turbutest  
The Turbutest (Figure 2) is used to train patients in the correct use
of the Turbohaler device. This device, available in several
European countries, is a replica connected to an electronic sensor
that measures peak inspiratory flow (PIF).11 The Turbutest grades
PIF visually (3 lights >60 l/min, 2 lights 40-60 l/min, 1 light 30-40
l/min, and no lights <30 l/min). According to the manufacturer’s
specifications, patients must be able to light at least 2 lights in
order to be able to generate a PIF sufficient to aerosolise the dry
powder into particles of respirable size when using a Turbohaler.
Inadequate PIF is one of the errors in DPI technique which may
critically reduce drug delivery. In addition, the Turbutest also
evaluates whether or not the patient has correctly performed the
initial rotation of the base of the Turbohaler required to prime
the inhaler; this is also a frequent and critical error in Turbohaler
use.5 In a large (n=600) group of adult asthmatic patients, the
Turbutest device revealed that 33% of them generated
inadequate PIF when using the Turbohaler, although none
reported difficulty in using it beforehand.11
3.  In-CheckDial  
The In-CheckDial (Clement Clarke International Ltd, UK; see
Figure 3) is a hand-held inspiratory airflow meter designed to
identify the most appropriate inhaler device for patients, based
on their ability to learn and achieve an optimal flow rate.12-15 It
accurately simulates the resistance encountered when using a
number of different inhalers currently on the market, and
measures the inspiratory flow rate achieved by the patient.
Although designed primarily for DPIs, it can also measure
inspiratory flow through an inhaler with no resistance such as a
pMDI, with or without a spacer, or a breath-actuated pMDI. The
In-CheckDial is composed of two parts: an inspiratory flow meter
and a rotating dial that selects different resistances (Figure 4). It
is supplied with a sterilisable mouthpiece and a card showing
optimal flow ranges for various devices. Patients unable to
achieve a flow rate within the optimal range for a given inhaler
should be provided with an alternative device. As mentioned,
both the speed and the acceleration of the inspiratory
manouevre when using a DPI critically affect the respirable
dose.8,16 Although the In-CheckDial does not measure the speed
of inhalation, Broeders and colleagues have shown that it
correlates with PIF when patients use DPIs.14 In one study,12 the
In-CheckDial showed that only a minority of COPD patients
could generate a PIF of 60 l/min which is reported to be the
minimum desirable flow rate when using the Turbohaler DPI.17
This finding is of importance since in vitro studies with the
Turbohaler device18,19 have highlighted the high variability of the
emitted dose below this inhalation rate. Although some clinical
response may be obtained at inhalation rates between 30 and 60
l/min through the Turbohaler device,20 the response might be
variable and in some cases slight. In another study,21 the In-
CheckDial detected that 14 out of 74 COPD patients (19%) were
not able to generate even the minimum (30 l/min) inhalation rate
reported to be required for use of the Turbohaler device.
Figure 2.  Turbutest. Figure 3.  In-CheckDial.
Figure 4.  The rotating dial to select inhaler resistance.
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Similarly, in a group of young children apparently experienced
with use of the Turbohaler device, the In-CheckDial revealed
adequate PIF (>60 l/min) in only 68%.15 In summary, the In-
CheckDial is a powerful tool that can greatly aid healthcare
providers when prescribing inhalers for the first time and when
checking technique. It provides real-time, objective feedback to
patients and may improve drug delivery and compliance.12-15 It
can be used to check PIF in patients of all ages when using DPIs,
whether new to the device or not.
4. Mag-Flo inhaler flow indicator  
The Mag-Flo inhaler flow indicator (Fyne Dynamics Ltd, UK)
evaluates patients’ ability to use a variety of DPIs including the
Turbohaler, the Diskus/Accuhaler, the Handihaler and the
Novolizer devices.22 This inhalation aid (Figure 5) uses a magnetic
flow sensor attached by an adaptor to the inhaler or training
placebo.22 When the patient inhales correctly, the magnetic flow
sensor is activated, switching on a battery powered green light,
providing visual, real-time feedback to the patient as to
inhalation speed.22 As far as we are aware, no published studies
have evaluated the accuracy of this device in flow detection as
well as its effect on patients’ inhalation technique. However, it
has the potential to teach patients using DPIs to inhale at an
appropriate rate and pick out those who cannot.
5. Aerosol Inhalation Monitor 
The Aerosol Inhalation Monitor (Vitalograph Ltd, Buckingham,
UK) is an electronic, desktop pMDI trainer that measures
patients’ inspiratory flow rate and monitors coordination of
inhalation with pressing the pMDI canister (Figure 6). It includes
a placebo pMDI with a sensitive flowhead which detects flow
once the patient starts inhaling. Feedback to the user is in the
form of different coloured lights and an analogue needle gauge
which indicates inspiratory flow rate, including a desired flow
range.23 During practice, the patient is asked to keep the needle
gauge within the desired flow range. After completion of the full
manouevre the device displays three coloured lights labelled
"firing", "delivery" and "breath hold". A green light indicates
that the patient performed the corresponding aspect of the
inhalation correctly. Conversely, a red light indicates an incorrect
technique. A secondary optional display provides an incentive
device utilising several lights overlain with cartoon figures.23
Thus, the Aerosol Inhalation Monitor provides health educators
and patients with both a visual and a quantitative assessment of
patients' inhalation technique wih pMDIs.23 Furthermore, the
device has been used in patients with acute asthma to verify
correct inhalation technique and as a teaching aid with variable
success.24 The Aerosol Inhalation Monitor has some
disadvantages: feedback is not fully interactive and is not
displayed across the entire time course of the manoevre, and
performance parameters are not operator programmable.
6. Inhalation Manager 
The Inhalation Manager is a user-friendly, computer-based
measuring instrument which enables testing of the inhalatory
capacity of patients using Turbohaler or Diskus/Accuhaler DPI
devices and the Autohaler breath-actuated pMDI. It assesses the
entire inspiratory manouevre and thus provides feedback to the
patient and the health professional. In one study,25 the Inhalation
Manager detected substandard inhalation technique in 1.5%,
16.7% and 38.9% of adult patients up to 60 years old using the
Autohaler, Diskus/Accuhaler and Turbohaler, respectively, rising
to 1.5%, 31.5% and 66.1% in those aged over 60 years old.
The Inhalation Manager also offers prediction of mass output
and particle size distribution from any individual inspiratory
manouevre through each of these inhaler devices, based on
measurements from compatible flow profiles measured in the
laboratory.8 Thus, the device offers the opportunity to hone
inhaler technique precisely in individual patients at least with the
currently covered devices.
Figure 5.  Mag-Flo inhaler flow indicater. Figure 6.  Aerosol Inhalation Monitor.
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7. SmartMist
The SmartMist Respiratory Management System (Aradigm
Corporation; Hayward, CA, US), is a hand-held breath-actuated,
microprocessor-controlled, accessory for use with pMDIs. This
electronic device, available in the USA, allows physicians to
evaluate objectively patient adherence to treatment by recording
the date and time of medication use.26-29 In addition to serving as
a reporting tool for compliance, the SmartMist records the
inspiratory flow rate and the ‘inspiratory firing volume’ (the
volume of air inhaled prior to actuation of the aerosol
generation) at the time of delivery. Therefore, it can be used for
assessing patients’ inhalation technique, and, consequently, for
training. The device prompts the patients to hold their breath for
10 seconds post-inhalation for optimum deposition.
Furthermore, the electronic peak flow meter in the device can be
used to assess and record the patient’s response to therapy.29 The
SmartMist (Figure 7) consists of a larger device that
accommodates the pMDI and actuator with only the mouthpiece
exposed. It contains a microprocessor that analyses an inspiratory
profile and automatically actuates the pMDI when predefined
conditions of inspiratory flow rate (25 to 60 L/min) and inspired
volume (250 to 500 mL) coincide, in order to minimise error in
inhalation technique.29 It provides immediate guidance on
technique with a flashing red light when inspiration is too rapid
(> 60 L/min), a solid green light when the inspiratory flow is
appropriate (25 to 60 L/min), or no light indicating insufficient
inspiratory flow (<25 L/min). Using red and green indicator lights
to provide instant feedback on proper inhalation technique, the
SmartMist guides patients to breathe slowly and evenly, and
automatically dispenses drug when the desired flow rate is
established. Information on inhalation technique and records
data on drug administration can be downloaded with the
accompanying cable onto a personal computer. The data can be
viewed and printed as a list of events or a series of graphs. The
validity and reliability of the SmartMist have been well
characterised,30 and clinical studies performed in asthma patients
have shown that the SmartMist improves inhalation technique
and diary accuracy for both medication use and pulmonary
function values.31
Multimedia training tools 
Recorded materials (videotape and digital media such as DVDs)
and web-based mutimedia information systems incorporating
video clips showing demonstration of correct use of pMDIs and
DPIs32-34 are frequently used for training patients. These
information systems offer an attractive alternative option for
teaching or reinforcing correct inhaler use, particularly for
children and other people who cannot read the information in
the manufacturer’s patient information leaflet. Multimedia
educational software delivers information to a laptop or
desktop computer screen using a range of visual and auditory
forms, including animation, video, voice-over, and sound effect.
The interactive capabilities of such programs and their potential
to store users’ responses can be harnessed to provide
personalised information in engaging forms such as games or
quizzes. In addition, using multimedia to deliver health
information has practical advantages: electronic information
stored on portable disk, computer disk or on a Web page is
easy to share across health care settings, and takes up much
less shelf space than paper-based methods. Recently, the
Aerosol Management Improvement Team (ADMIT) provided its
web platform34 with interactive tools on how to use the most
popular inhalation devices throughout the world correctly.
Using multimedia may also be more effective than print-based
information, as the need for some active input from the
recipient is claimed to make learning both easier and more
enjoyable than with conventional methods.35 A degree of
choice can be offered as to how information is presented (e.g.
language, age, gender, ethnicity). This could increase the
acceptability and personal relevance of the information, and
help inhaler users to feel more involved in their own health
care. Savage and Goodyer36 compared, in asthma patients, the
effects of brief exposure to standard information on correct
pMDI use, given by the manufacturer’s patient information
leaflet and by a multimedia program. They found that both
information methods induced similar improvements in global
inhaler technique ratings in around a third of patients. There
were differences between the two information-giving methods
in terms of engaging attention, and in the observed changes in
specific aspects of technique. However, unlike paper leaflets,
the information provided by multimedia takes up little space, is
easy to share, and the technology required is well established
and relatively low cost.36
Figure 7.  SmartMist.
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Conclusion
Most professionals would accept that no inhaled drug can
effectively treat asthma or COPD unless it reaches the airways,
so that using delivery devices to achieve this with maximum
efficiency is the cornerstone of management of these
diseases. Although guidelines acknowledge that inhalers
should be prescribed only after patients have been trained to
use them properly and have demonstrated this ability,37,38
many studies4,5 suggest that this critical aspect of patient care
is poorly addressed. Yet health professionals now have a
number of tools available with which to hone perfect inhaler
technique in each individual patient. Incorrect or inefficient
inhaler usage may be a direct consequence of poor
instruction,39 but this is improved (albeit temporarily) by
training.40,41 The quality of this training is of paramount
importance. The manufacturer’s instruction sheet alone is
ineffective in achieving correct technique.42-44 Patients with
asthma or COPD using an inhaler for the first time are more
likely to demonstrate the correct technique after receiving
verbal instruction than after reading the manufacturer’s
leaflet.44 Instruction provided in groups or by video can also be
as effective as one-to-one instruction in improving
technique.45
As we have stressed in this article, there is now abundant
scope for excellent practical instruction with various aids.
Inhaler technique education is best delivered by verbal
instructions and physical demonstration of the technique by a
skilled educator, either face to face or by video.46,47
Demonstrating the steps can also help overcome language
barriers.48 What is still missing perhaps is the required time
and organisation. Inhaler technique must be rechecked and
education must be reinforced regularly in order to maintain
correct technique, since inhaler technique deteriorates again
after education.4,5 Surveys continue to suggest, however, that
substantial proportions of patients prescribed inhalers receive
no verbal instruction at all,43,49 or a brief, one-off session.50
Follow-up is important when one considers that as early as
three days after successful instruction, more than a third of
patients may no longer use their DPI correctly,43 but they fare
much better with repetition.51 Finally, “going through the
motions” of inhaler training, even if repeated, although
essential is not always enough. The health professional must
“go the extra mile” to perfect inhaler technique and eliminate
critical errors that can vastly reduce inhaler performance.
Training devices to facilitate this are easy to use and in some
cases measure patients’ inspiratory flow, so that good
technique can be learned quickly, even by children, and
checked objectively. 
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